Stock listing

Equillium, Inc.

Selected listing: A2N7B3 · LS · EUR · DE

Equillium, Inc. (Lang & Schwarz: A2N7B3), Health Technology. Latest release Oct 6, 2026: Equillium Announces Poster Presentation at the 50th Anniversary La…

A2N7B3:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2N7B3
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Equillium, Inc.

Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference

October 6, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

October 5, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

October 4, 2026

Equillium Announces Poster Presentations at the 7th International AHR Conference

September 28, 2026

Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum

September 16, 2026

All Equillium, Inc. news →

Research Equillium, Inc.

Equillium, Inc. company profile

View the public company page for Equillium, Inc. on 6ix.

Equillium, Inc. news

Read company news and market updates connected to Equillium, Inc..

Equillium, Inc. investor events

Find investor webinars, events, and replay context for Equillium, Inc..